PCM
MRK icon

Pointe Capital Management’s Merck MRK Stock Holding History

Pointe Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$292K Buy
2,431
+95
+4% +$11K 0.14% 121
2025
Q4 		$246K Buy
+2,336
New +$219K 0.12% 135
2025
Q3 		– Sell
-2,683
Closed -$212K – 156
2025
Q2 		$212K Sell
2,683
-48
-2% -$3.81K 0.11% 152
2025
Q1 		$245K Hold
2,731
– – 0.14% 136
2024
Q4 		$272K Sell
2,731
-2,386
-47% -$246K 0.16% 126
2024
Q3 		$581K Buy
5,117
+222
+5% +$26.4K 0.34% 80
2024
Q2 		$606K Buy
4,895
+48
+1% +$6.18K 0.38% 71
2024
Q1 		$640K Hold
4,847
– – 0.39% 66
2023
Q4 		$528K Buy
4,847
+34
+0.7% +$3.53K 0.37% 73
2023
Q3 		$495K Buy
4,813
+17
+0.4% +$1.83K 0.37% 65
2023
Q2 		$553K Buy
4,796
+263
+6% +$29.9K 0.42% 63
2023
Q1 		$482K Sell
4,533
-78
-2% -$8.42K 0.35% 74
2022
Q4 		$512K Sell
4,611
-2,466
-35% -$252K 0.39% 68
2022
Q3 		$609K Buy
7,077
+79
+1% +$7.05K 0.49% 53
2022
Q2 		$638K Hold
6,998
– – 0.48% 55
2022
Q1 		$574K Buy
6,998
+295
+4% +$23.3K 0.37% 71
2021
Q4 		$514K Sell
6,703
-62
-0.9% -$4.94K 0.31% 83
2021
Q3 		$508K Buy
6,765
+1,784
+36% +$136K 0.35% 80
2021
Q2 		$387K Sell
4,981
-93
-2% -$6.92K 0.27% 102
2021
Q1 		$373K Buy
5,074
+54
+1% +$3.98K 0.26% 97
2020
Q4 		$392K Sell
5,020
-167
-3% -$12.8K 0.33% 87
2020
Q3 		$411K Buy
5,187
+93
+2% +$7.28K 0.36% 78
2020
Q2 		$376K Hold
5,094
– – 0.34% 85
2020
Q1 		$374K Sell
5,094
-390
-7% -$30.7K 0.36% 70
2019
Q4 		$476K Sell
5,484
-14
-0.3% -$1.15K 0.4% 74
2019
Q3 		$442K Sell
5,498
-7
-0.1% -$561 0.37% 81
2019
Q2 		$440K Sell
5,505
-3
-0.1% -$230 0.36% 82
2019
Q1 		$437K Buy
5,508
+1,106
+25% +$82.7K 0.37% 82
2018
Q4 		$321K Sell
4,402
-38
-0.9% -$2.68K 0.31% 93
2018
Q3 		$301K Buy
4,440
+233
+6% +$14.8K 0.24% 120
2018
Q2 		$244K Buy
4,207
+31
+0.7% +$1.75K 0.21% 130
2018
Q1 		$217K Buy
4,176
+37
+0.9% +$2K 0.19% 137
2017
Q4 		$222K Sell
4,139
-100
-2% -$5.54K 0.18% 140
2017
Q3 		$259K Buy
4,239
+44
+1% +$2.67K 0.19% 135
2017
Q2 		$257K Sell
4,195
-197
-4% -$12K 0.18% 138
2017
Q1 		$266K Buy
+4,392
New +$266K 0.2% 128
2016
Q4 		– Sell
-5,435
Closed -$324K – 209
2016
Q3 		$324K Sell
5,435
-700
-11% -$40.9K 0.24% 119
2016
Q2 		$337K Sell
6,135
-304
-5% -$16.2K 0.25% 115
2016
Q1 		$325K Buy
6,439
+130
+2% +$6.37K 0.26% 113
2015
Q4 		$318K Buy
6,309
+1,137
+22% +$57.3K 0.23% 119
2015
Q3 		$244K Sell
5,172
-1,269
-20% -$67.4K 0.15% 140
2015
Q2 		$350K Buy
6,441
+210
+3% +$11.8K 0.16% 131
2015
Q1 		$342K Buy
+6,231
New +$353K 0.16% 113

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pointe Capital Management's MRK Position: Q1 2026 in Review

Pointe Capital Management increased its Merck (MRK) stake by 4.1% in Q1 2026, buying an estimated $11K and bringing the position to 2,431 shares worth $292K. The position accounts for 0.14% of the portfolio, ranked #121.

Pointe Capital Management first reported a position in MRK in Q1 2015 and has held it in 43 quarters since. The position peaked at $640K in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Pointe Capital Management held 2,431 shares of Merck worth $292K as of Q1 2026.
  • Pointe Capital Management bought 95 Merck shares in Q1 2026, an estimated $11K.
  • Merck made up 0.14% of Pointe Capital Management's portfolio in Q1 2026, its #121 holding.
  • Pointe Capital Management first reported a position in Merck in Q1 2015 and has held it in 43 quarters since.
  • Pointe Capital Management's Merck position peaked at $640K in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Pointe Capital Management's 13F filing for Q1 2026, filed 15 May 2026.